___NSF has Cytodyn on their website...wonder how l
Post# of 148179
(Total Views: 437)
Posted On: 10/06/2021 2:42:29 PM
___NSF has Cytodyn on their website...wonder how long that will be visible?
March 25, 2021...Amarex executed a rush submission to the FDA for (CUA). Amarex prepared the submission in a matter of days which included writing a new trial protocol...the TYPICAL submission process can take 5 weeks or more.
March 27, 2021...Amarex executed a RUSH submission to the US FDA for a PCR-based IVD for rapid detection of the (SARS-CoV2). The IVD has been through the regulatory approval process in Korea.
March 30, 2021...FDA cleared a second IND for a phase2 randomized trial to treat mildly to moderate ill Coronvirus patients with LeronLimab....Amarex is currently MANAGING the trial.
April 1, 2021...Cytodyn filed a IND amendment with the FDA for a protocol to treat severely ill COVID-19 patients with LeronLimab...mortality rate at 2 weeks. Amarex PREPARED that submission.
"I count myself lucky to work with our Amarex Team"..."they're incredibly caring, dedicated people as well as skilled experts... who have been quick to adapt to this rapidly changing situation."__Amarex Pres. & CEO
Dr. Kazem Kazempour
With All that Rushing, Managing, Preparing and Submitting...kinda feels like we got the backburner Treatment..
March 25, 2021...Amarex executed a rush submission to the FDA for (CUA). Amarex prepared the submission in a matter of days which included writing a new trial protocol...the TYPICAL submission process can take 5 weeks or more.
March 27, 2021...Amarex executed a RUSH submission to the US FDA for a PCR-based IVD for rapid detection of the (SARS-CoV2). The IVD has been through the regulatory approval process in Korea.
March 30, 2021...FDA cleared a second IND for a phase2 randomized trial to treat mildly to moderate ill Coronvirus patients with LeronLimab....Amarex is currently MANAGING the trial.
April 1, 2021...Cytodyn filed a IND amendment with the FDA for a protocol to treat severely ill COVID-19 patients with LeronLimab...mortality rate at 2 weeks. Amarex PREPARED that submission.
"I count myself lucky to work with our Amarex Team"..."they're incredibly caring, dedicated people as well as skilled experts... who have been quick to adapt to this rapidly changing situation."__Amarex Pres. & CEO
Dr. Kazem Kazempour
With All that Rushing, Managing, Preparing and Submitting...kinda feels like we got the backburner Treatment..
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼